Apricus Wins EU Approval for Vitaros for ED

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Apricus Biosciences, Inc.("Apricus Bio" or the "Company") (Nasdaq: APRI) (http://www.apricusbio.com),today announced that its marketing application for Vitaros^®, indicated forthe treatment of patients with erectile dysfunction ("ED"), has been approvedthrough the European Decentralized Procedure ("DCP").Under the DCP, Apricus Bio filed its application for marketing approvaldesignating Netherlands as the Reference Member State ("RMS") on behalf ofnine other European Concerned Member States ("CMS") participating in theprocedure. The CMS include France, Germany, Italy, UK, Ireland, Spain, Sweden,Belgium and Luxembourg. The Company will continue to work independently aswell as with its commercialization partners, Sandoz, Takeda, and Bracco forthe next step of obtaining national phase approvals in order to make Vitaros^®ready to launch in each of the included territories across Europe.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!